drugset / Trial / NCT00765492

AZD8529 Multiple Ascending Dose Study in Healthy Subjects

NCT00765492

Phase 1 Completed 47 enrolled AstraZeneca
RandomizedSingle-groupQuadruple-blind

Summary

This is a study to evaluate safety, tolerability, PK and PD effects of orally administered AZD8529 after multiple ascending doses

Timeline

Start
2008-10
Primary completion
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8529 Other / unclassified Oral

Indications

No indication recorded.